ArticleCancer innovation2025

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia: A Case Report.

Mengyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.